Generate a tailored SOP for Dr. Steven Gerondakis. Improve your application with a focused, well-structured draft.
Steven Gerondakis is an Adjunct Professor (Research) at Monash University, where he heads the Immune Cancer Cell Signalling Laboratory. His research focuses on the Nuclear Factor kappa B (NF-kB) signal transduction pathway and its critical role in the immune system and disease pathology. The laboratory employs genetically modified mice to explore how NF-kB regulates normal development, cellular differentiation, and immune functions, particularly in relation to autoimmune diseases and cancer. The long-term aim is to discover therapeutic strategies by manipulating NF-kB transcription factor activities. Gerondakis' work aligns with the UN Sustainable Development Goals, specifically contributing to initiatives that align with research in areas such as immunity, inflammation, and cancer. He has led significant projects involving key collaborations with other prominent researchers.
Monash University • Melbourne, VIC, Australia
Leading research in immune cancer cell signaling and NF-kB pathways.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.